ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT03394404
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 140 participants
- Sponsor
- Registry
-
NCT03394404
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03394404. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-08 (actual); primary completion 2021-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation
- Acronym
- PHENOTYPE-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- ECG-I mapping and PVI
- Lead sponsor
- Barts & The London NHS Trust
Record details
- Record id
cardio:ct-nct03394404- Content hash
72ebacae99323de1c59b908220c9d83ee34303d87036b7579606deda468b5575